The objective for this webinar is to bring regulatory and industry representatives together to discuss their perspectives on implementation of patient-centric specifications.
The rationale for patient-centric or clinically relevant specifications are articulated in two quotes from “FDA Pharmaceutical Quality Oversight: One Quality Voice ”
“Clinically relevant specifications can be defined as a set of criteria and acceptance ranges to which drug products should conform in order to deliver the therapeutic benefit indicated in the label.”
“Clinically relevant specifications increase flexibility within the pharmaceutical manufacturing sector while maintaining quality by establishing acceptance criteria based on clinical relevance, instead of process capability or manufacturing process control.”
Several recent publications from Industry have focused on the establishment of patient-centric specifications.
This webinar will focus on the regulatory expectations for a company to establish clinically relevant specifications. The session will include brief presentations from industry and regulators and will be followed by an extended panel discussion.
*ISPE Membership is required for these registration rates.
Become a member today
Gain the knowledge and competitive edge you need to succeed in the pharmaceutical and biopharmaceutical engineering industries and join more than 18,000 pharma professionals from around the world by becoming an ISPE Member.